Skip to main content

Ricks Thomas G

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Ricks Thomas G as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

OVV Ovintiv Inc.

Director4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 8, 2022 (view filing)Jun 71 dayRicks Thomas GDirectorSSale−19.2K$59.50−$1.14M−14.2%116.3K after
May 24, 2022 (view filing)May 231 dayRicks Thomas GDirectorSSale−10.0K$50.00−$500.0K−6.9%135.5K after
Apr 19, 2022 (view filing)Apr 181 dayRicks Thomas GDirectorSSale−10.0K$53.73−$537.3K−6.4%145.5K after
Apr 6, 2022 (view filing)Mar 316 daysLateRicks Thomas GDirectorPPurchase+19––0.0%56.9K after

FTH Faeth Therapeutics, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 13, 2021 (view filing)Dec 9-104 daysRicks Thomas GDirectorPPurchase+40.0K$6.24+$249.6K+13.3%341.8K after2 lots